The Many Faces of Scleroderma

Rheumatic Disease Clinics of North America

Volumn 34, Issue 1, 2008, Pages 1-15

  Steen, Virginia D ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA DIRECTED RNA POLYMERASE III; PM ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; SCL 70 ANTIBODY; TH ANTIBODY; TO ANTIBODY; TOPOISOMERASE ANTIBODY; UNCLASSIFIED DRUG;

BASIC RESEARCH; CLINICAL FEATURE; COMPREHENSION; DEMOGRAPHY; DIFFUSE CUTANEOUS SCLERODERMA; GENETICS; HUMAN; LIMITED SCLERODERMA; MONITORING; OCCUPATIONAL THERAPY; PATHOGENESIS; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCLERODERMA; SURVIVAL;

EID: 40149100153     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.12.001     Document Type: Review

References (80)

1. T.G. Benedek G.P. Rodnan The early history and nomenclature of scleroderma and of its differentiation from sclerema neonatorum and scleroedema Semin Arthritis Rheum 12 1982 52 67
2. V.D. Steen D.L. Powell T.A. Medsger Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis Arthritis Rheum 31 1988 196 203
3. E.E. Velayos A.T. Masi M.B. Stevens The ‘CREST’ syndrome. Comparison with systemic sclerosis (scleroderma) Arch Intern Med 139 1979 1240 1244
4. A.T. Masi G. Rodman T. Medsger Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 1980 581 590
5. N.F. Rothfield G.P. Rodnan Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma) Arthritis Rheum 11 1968 607 617
6. R. Salerni G.P. Rodnan D.F. Leon Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma) Ann Intern Med 86 1977 394 399
7. A.S. Douvas M. Achten E.M. Tan Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma J Biol Chem 254 1979 10514 10522
8. Y. Moroi C. Peebles M.J. Fritzler Autoantibody to centromere (kinetochore) in scleroderma sera Proc Natl Acad Sci U S A 77 1980 1627 1631
9. E.C. Leroy C. Black R. Fleischmajer Scleroderma (systemic sclerosis): classification, subsets and pathogenesis J Rheumatol 15 1988 202 205
10. E.M. Tan G.P. Rodnan I. Garcia Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome Arthritis Rheum 23 1980 617 625
11. M. Kikuchi T. Inagaki Bibliographical study of the concurrent existence of anticentromere and antitopoisomerase I antibodies Clin Rheumatol 19 2000 435 441
12. D.E. Furst P.J. Clements M. Saab Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration Ann Rheum Dis 43 1984 794 801
13. D.G. Sacks Y. Okano V.D. Steen Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody J Rheumatol 23 1996 639 642
14. T. Sugimoto M. Soumura K. Danno Scleroderma renal crisis in a patient with anticentromere antibody-positive limited cutaneous systemic sclerosis Mod Rheumatol 16 2006 309 311
15. V.D. Steen T.A. Medsger Jr. T.A. Osial Jr. Factors predicting development of renal involvement in progressive systemic sclerosis Am J Med 76 1984 779 786
16. V.D. Steen G.R. Owens G.J. Fino Pulmonary involvement in systemic sclerosis (scleroderma) Arthritis Rheum 28 1985 759 767
17. C.V. Oddis Y. Okano W.A. Rudert Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations Arthritis Rheum 35 1992 1211 1217
18. Y. Okano T.A. Medsger Jr. Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis Arthritis Rheum 33 1990 1822 1828
19. Y. Okano V.D. Steen T.A. Medsger Jr. Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis Arthritis Rheum 35 1992 95 100
20. Y. Okano V.D. Steen T.A. Medsger Jr. Autoantibody reactive with RNA polymerase III in systemic sclerosis Ann Intern Med 119 1993 1005 1013
21. D. Falkner J. Wilson N. Fertig Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin) J Rheumatol 27 2000 1196 1202
22. D. Falkner J. Wilson T.A. Medsger Jr. HLA and clinical associations in systemic sclerosis patients with anti- Th/To antibodies Arthritis Rheum 41 1998 74 80
23. R.W. Johnson M.B. Tew F.C. Arnett The genetics of systemic sclerosis Curr Rheumatol Rep 4 2002 99 107
24. P.A. Morel H.J. Chang J.W. Wilson HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies Hum Immunol 42 1995 35 42
25. P.A. Morel H.J. Chang J.W. Wilson Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele Hum Immunol 40 1994 101 110
26. S. Assassi F.C. Arnett J.D. Reveille Clinical, immunologic, and genetic features of familial systemic sclerosis Arthritis Rheum 56 2007 2031 2037
27. C. Feghali-Bostwick T.A. Medsger Jr. T.M. Wright Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies Arthritis Rheum 48 2003 1956 1963
28. M. Kuwana J. Kaburaki F.C. Arnett Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody Arthritis Rheum 42 1999 465 474
29. R.J. Allcock I. Forrest P.A. Corris A study of the prevalence of systemic sclerosis in northeast England Rheumatology (Oxford) 43 2004 596 602
30. M.D. Mayes J.V. Lacey Jr. J. Beebe-Dimmer Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population Arthritis Rheum 48 2003 2246 2255
31. O.C. Meyer N. Fertig M. Lucas Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis J Rheumatol 34 2007 104 109
32. C. Ferri G. Valentini F. Cozzi Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients Medicine (Baltimore) 81 2002 139 153
33. U. Picillo S. Migliaresi M.R. Marcialis Clinical setting of patients with systemic sclerosis by serum autoantibodies Clin Rheumatol 16 1997 378 383
34. C.C. Bunn C.P. Denton X. Shi-wen Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis Br J Rheumatol 37 1998 15 20
35. L.J. McNeilage U. Youngchaiyud S. Whittingham Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma Arthritis Rheum 32 1989 54 60
36. X. Zhou F.K. Tan N. Wang Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence Arthritis Rheum 48 2003 2585 2592
37. F.K. Tan N. Wang M. Kuwana Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations Arthritis Rheum 44 2001 893 901
38. R. Brouwer W.T. Vree Egberts G.J. Hengstman Autoantibodies directed to novel components of the PM/Scl complex, the human exosome Arthritis Res 4 2002 134 138
39. F. Goldblatt T.P. Gordon S.A. Waterman Antibody-mediated gastrointestinal dysmotility in scleroderma Gastroenterology 123 2002 1144 1150
40. M.L. Harris A. Rosen Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies Curr Opin Rheumatol 15 2003 778 784
41. P.Q. Hu N. Fertig T.A. Medsger Jr. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis Arthritis Rheum 48 2003 1363 1373
42. M. Kuwana J. Kaburaki T. Mimori Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis Arthritis Rheum 43 2000 1074 1084
43. S. Sato Y. Hamaguchi M. Hasegawa Clinical significance of anti-topoisomerase I antibody levels determined by ELISA in systemic sclerosis Rheumatology (Oxford) 40 2001 1135 1140
44. Y. Okano Antinuclear antibody in systemic sclerosis (scleroderma) Rheum Dis Clin North Am 22 1996 709 735
45. F.C. Arnett Is scleroderma an autoantibody mediated disease? Curr Opin Rheumatol 18 2006 579 581
46. S.S. Ahmed F.K. Tan F.C. Arnett Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies Arthritis Rheum 54 2006 2250 2262
47. F.K. Tan F.C. Arnett J.D. Reveille Autoantibodies to fibrillin 1 in systemic sclerosis: ethnic differences in antigen recognition and lack of correlation with specific clinical features or HLA alleles [in process citation] Arthritis Rheum 43 2000 2464 2471
48. S. Sato I. Hayakawa M. Hasegawa Function blocking autoantibodies against matrix metalloproteinase-1 in patients with systemic sclerosis J Invest Dermatol 120 2003 542 547
49. S.S. Baroni M. Santillo F. Bevilacqua Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis N Engl J Med 354 2006 2667 2676
50. K.T. Ho J.D. Reveille The clinical relevance of autoantibodies in scleroderma Arthritis Res Ther 5 2003 80 93
51. H.D. Tramposch C.D. Smith J.L. Senecal A long-term longitudinal study of anticentromere antibodies Arthritis Rheum 27 1984 121 124
52. T. Dick R. Mierau P. Bartz-Bazzanella Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis Ann Rheum Dis 61 2002 121 127
53. S. Hildebrandt G. Jackh S. Weber A long-term longitudinal isotypic study of anti-topoisomerase I autoantibodies Rheumatol Int 12 1993 231 234
54. A. Ruffatti A. Calligaro C. Ferri Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases J Clin Lab Immunol 16 1985 227 229
55. G.C. Kane J. Varga E.F. Conant Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status Respir Med 90 1996 223 230
56. S. Morelli C. Barbieri A. Sgreccia Relationship between cutaneous and pulmonary involvement in systemic sclerosis J Rheumatol 24 1997 81 85
57. V. Steen T.A. Medsger Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement Arthritis Rheum 48 2003 516 522
58. B. Freundlich S.A. Jimenez V.D. Steen Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial Arthritis Rheum 35 1992 1134 1142
59. A.J. Macgregor R. Canavan C. Knight Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival Rheumatology (Oxford) 40 2001 453 459
60. G. Harvey C. Black P. Maddison Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives J Rheumatol 24 1997 477 484
61. H. Van Eenennaam J.H. Vogelzangs L. Bisschops Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations Clin Exp Immunol 130 2002 532 540
62. H. Van Eenennaam J.H. Vogelzangs D. Lugtenberg Identity of the RNase MRP- and RNase P-associated Th/To autoantigen Arthritis Rheum 46 2002 3266 3272
63. H. Imai R.L. Ochs K. Kiyosawa Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies Am J Pathol 140 1992 859 870
64. C.P. Strassburg M.P. Manns Antinuclear antibody (ANA) patterns in hepatic and extrahepatic autoimmune disease J Hepatol 31 1999 751
65. R.J. Kipnis J. Craft J.A. Hardin The analysis of antinuclear and antinucleolar autoantibodies of scleroderma by radioimmunoprecipitation assays Arthritis Rheum 33 1990 1431 1437
66. G.M. Mitri M. Lucas N. Fertig A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement Arthritis Rheum 48 2003 203 209
67. V.D. Steen M. Lusas N. Fertig Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nuclear antibody J Rheumatol 34 11 2007 2230 2235
68. V.D. Steen Autoantibodies in systemic sclerosis Semin Arthritis Rheum 35 1 2005 35 42
69. M. Aringer G. Steiner J.S. Smolen Does mixed connective tissue disease exist? Yes Rheum Dis Clin North Am 31 2005 411 420
70. P.J. Maddison Autoantibodies and clinical subsets: relevance to scleroderma [editorial] [in process citation] Wien Klin Wochenschr 112 2000 684 686
71. I. Lundberg S. Antohi K. Takeuki Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome J Autoimmun 14 2000 267 274
72. V.D. Steen T.A. Medsger Jr. Epidemiology and natural history of systemic sclerosis Rheum Dis Clin North Am 16 1990 1 10
73. A. Perera N. Fertig M. Lucas Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody Arthritis Rheum 56 2007 2740 2746
74. V.D. Steen C. Conte G.R. Owens Severe restrictive lung disease in systemic sclerosis Arthritis Rheum 37 1994 1283 1289
75. M. Santiago M. Baron M. Hudson Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA J.Rheumatol 34 2007 1528 1534
76. M. Kuwana Y. Okano J.P. Pandey Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis Arthritis Rheum 52 2005 2425 2432
77. O.H. Gunduz N. Fertig M. Lucas Systemic sclerosis with renal crisis and pulmonary hypertension: a report of eleven cases Arthritis Rheum 44 2001 1663 1666
78. V.D. Steen T.A. Medsger Jr. Changes in causes of death in systemic sclerosis Ann Rheum Dis 34 2007 2230 2235
79. H. Penn A.J. Howie E.J. Kingdon Scleroderma renal crisis: patient characteristics and long-term outcomes QJM 100 2007 485 494
80. L. Teixeira A. Mahr A. Berezne Scleroderma renal crisis, still a life-threatening complication Ann N Y Acad Sci 1108 2007 249 258